orbimed english  portfolio immunotherapy gene therapy gene editing the future of health sciences is closer than you think many technologies with the potential to cure disease are advancing rapidly how long can healthy humans live  years  years our portfolio companies are working hard to find out industry sector all biopharmaceutical diagnosticstools healthcare services medical device healthcare it region all asia middle east north america europe sort by alphabetical newest oldest acutus developing a novel electroanatomical mapping catheter more adaptimmune focused on the use of t cell therapy to treat cancer more adicet bio adicet bio inc is developing a novel universal immunecell more adimab fully integrated yeastbased antibody discovery maturation and more aeglea biotherapeutics developing novel treatments using engineered human amino more aerpio developing treatments for disorders of the vasculature with more affimed discovering and developing next generation antibody therapies more aige hospital a leading eye hospital chain in the central region of china more aims multispecialty tertiary care hospital in north india more ait applied immune technologies ait is a drug development more ak medical developing a novel electroanatomical mapping catheter for more alector developing antibody therapeutics to treat more alpine immune sciences alpine immune sciences is focused on developing novel more amoy diagnostics the leader in cancer molecular diagnostics in china more armo biosciences discovering and developing novel immunooncology drugs more arsanis biosciences developing antibody therapeutics for infectious diseases more arvinas arvinas is a pharmaceutical company focused on developing more ascendis pharma ascendis pharma develops differentifaated prodrug versions more atox bio atox bio is a late stage biotechnology company that develops more audentes therapeutics developing gene therapy products for rare diseases more augmedix augmedix commercializes a service that frees doctors from more avedro inc avedro is a privately held medical device and more avitide developing custom affinity purification solutions for more balance therapeutics balance therapeutics is an rd company focused on more bharat serums and vaccines developing and manufacturing a wide range of products such more biolinerx building a portfolio of products for various indications more bonovo orthopedics providing the latest orthopedic products to the more cbt pharmaceuticals a spinoff from crown biosciences dedicated to oncology more cerapedics developing and commercializing products for the orthopedic more chemclin a leader to provide affordable diagnostics products more chemomab chemomab is developing therapeutic antibodies as more cleave biosciences discovering and developing therapeutics targeting more clementia developing treatments for diseases of heterotopic more compass therapeutics compass therapeutics is seeking to cure various cancer more corvus pharmaceuticals developing novel immunotherapies for the treatment of cancer more credit pharma credit pharma is a central nervous system focused leading more crown bioscience a preclinical cro with leadership in translational oncology more dih a leading provider of robotics and intelligent systems more dimension therapeutics developing aav therapeutics for rare diseases more domain surgical develops and commercializes a thermal surgical energy more echosens french hightechnology company specializing in more eddingpharm commercializing a broad range of pharmaceutical products in more emendo biotherapeutics emendo develops biotherapeutics based on its novel gene editing more eurolife healthcare one of india’s leading manufacturers of intravenous iv fluids more futurx pharma incubator established with jj and takeda more gc aesthetics develops and manufactures breast and aesthetic implants for more gcrise pharmaceutical a leading chinese pharmaceutical company focused on women more genewiz a leading global genomics service company more glaukos transforming glaucoma therapy more good start genetics developing improved methods of prepregnancy testing more graybug vision graybug vision is developing products to reduce the frequency of more guardant health guardant health is a private diagnostics company focusing on more hls therapeutics hls therapeutics is a specialty pharmaceutical more igenica discovering and developing breakthrough more inspire medical systems developed implanted neurostimulation device for more intellia therapeutics intellia is a leading gene editing company focused on more intercept developing therapeutics for liver  metabolic diseases more invitae offering  genetic diagnostics for hereditary disorders more kala pharmaceuticals kala pharmaceuticals is a clinical stage pharmaceutical more keystone heart developing procedural tools and accessories for use during more laxmi dental leading dental laboratory in india manufacturing dental more logicbio logicbio develops gene therapy vectors for previously more loxo oncology developing targeted cancer therapies for more marinus pharmaceuticals marinus pharmaceuticals is a clinical stage more mdclone mdclone was founded to address one of the most critical more medigus developing innovative endoscopic procedures and devices more mid labs an innovative ophthalmic medical device company with more nabriva developing pleuromutilins a new class of antibiotics more natera provides preconception and prenatal genetic testing more nerre therapeutics nerre therapeutics is developing a portfolio of neurokinin more netmedscom netmedscom is a leading online pharmacy marketplace in india more nextcure nextcure is a biopharmaceutical company focused on more novellusdx a personalized medicine diagnostics company assessing the more nucleix nucleix develops manufactures and markets more nutrinia nutrinia treats rare diseases of the gi tract by developing more obseva sa obseva is a swissbased pharmaceutical company developing small more omniguide surgical develops and markets an advanced surgical energy delivery more oric pharmaceuticals oric pharmaceuticals is focused on discovering and more ornim medical developing devices monitoring hemoglobin blood more otic pharma oticpharma is seeking to develop ear nose and throat products more otonomy developing novel drug therapies for disorders of the inner more oxonc development conducting clinical studies of xalkori in ros advanced more pharmabcine developing fully human therapeutic antibodies for the more pharming group nv netherlandsbased public biotechnology company more pieris ag discovering and developing anticalins® a novel class more pionyr immunotherapeutics pionyr is developing cancer immunotherapies that target the more pmv pharma developing p modulators for the treatment of cancer more practice fusion a leading provider of electronic healthcare record services more principia biopharma developing novel therapeutics using reversible more promentis pharmaceuticals promentis is developing compounds for the treatment of cns more proteus digital health proteus is a private digital medicine platform company more rapid pathogen screening marketer of rapid pointofcare diagnostic tests more rdd pharma developing drugdevice combinations for the treatment more recro pharma clinical stage specialty pharmaceutical company more redhill biopharma developing late clinicalstage formulations and combinations more response biomedical corp manufactures and markets rapid onsite diagnostic tests more reviral reviral is an emerging ukbased biopharma aiming to more rhythm pharmaceuticals rhythm is a biopharmaceutical company developing more roka bioscience commercializing novel nucleic acid testing methods more rpharm rpharm us is a specialty pharmaceutical company focused on more scpharmaceuticals scpharmaceuticals is developing a portfolio of pharmaceutical more selecta biosciences developing firstinclass integrated synthetic more senico healthcare leading provider of kidney and specialty care services in the more sibone commercializing the ifuse implant system for minimally more sientra inc developing products for the plastic surgery and more sierra oncology sierra oncology is a clinical stage drug development company more sikka software enhancing practice economics and improving quality of care more singulex developing and commercializing the next generation of more smartzyme smartzyme innovation is a life science company using a more sonendo developing innovative devices for root canal treatment more steadymed steadymed is a specialty pharmaceutical company focused on the more strides shasun service provider to the global pharmaceutical industry more suraksha diagnostic leading diagnostic chain in east india more surya a prominent neonatal and pediatric care hospital chain more symbiomix therapeutics a new focus on womens health more syndax pharmaceuticals syndax is a latestage biopharmaceutical company more synlogic synlogic engineers synthetic biotics a new class of medicines more tela bio developing novel biologic mesh implant products more therachon therachon is a biotech company specialized in research and more tigertext provides secure messaging in healthcare applications more tp therapeutics tp therapeutics is a clinicalstage biopharmaceutical company more treato the voice of the patient  big data analytics of patient more tricida preclinical stage biopharmaceutical company focused on more turnstone biologics turnstone is developing a firstinclass engineered oncolytic more tyto tytocare provides the missing link in telehealth  a more unilife develops and supplies injectable drug delivery systems more upper biotech a leading poct diagnostics company in china more verona pharma verona pharma is a ukbased clinical stage biopharmaceutical more viewray developing next generation radiotherapy technologies more waterstone pharmaceuticals chinabased specialty pharmaceutical company more whale imaging developing and commercializing medical imaging solutions more xenon pharmaceuticals xenon is a clinicalstage biopharmaceutical company discovering more xtant medical xtant medical is a comprehensive supplier of orthopedic more zai labratory a leading biotech company based in china more load more our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team orbimed english  contact us orbimeds team includes over  experienced professionals with expertise in the life sciences industry medicine finance and law investors if you are an investor interested in learning more about our funds please contact carter neild or bill price at    or send us an email companies if you would like to meet with our team please send us a description of your firm and the type of financing you are seeking by email for general inquiries please contact us at      new york  lexington avenueat rd street th floornew york ny       san francisco  mission bay blvd southsuite san francisco ca       mumbai suite f  grand hyatt plazasantacruz eastmumbai  india       herzliya  medinat hayehudim stbuilding e th floorherzliya  israel      shanghai unit  raffles cityshanghai office tower xizang middle roadshanghai  pr china    our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team orbimed english  about us from biopharmaceuticals to medical devices diagnostics and healthcare services orbimed is scouting the globe for innovations that will help ensure humanity lives healthier longer and more productive lives we have been investing globally for over  years across the healthcare industry from earlystage private companies to large multinational corporations our team of over  distinguished scientific medical investment and other professionals manage approximately  billion across public and private company investments worldwide   life sciences focus the global healthcare industry sits at the intersection of several powerful longterm growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease these trends have caused a steady increase in the level of healthcare spending in the industrialized world led by the us which now spends over  of its gdp on healthcare the healthcare industrys powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities our strategies orbimed invests across the global healthcare industry from seedstage venture capital to large publiclytraded companies investments are made in one of three strategies public equity private equity and royalty opportunities public equity orbimed manages a series of public equity funds including longshort eventdriven funds and closedend investment trusts we invest across all types of publiclytraded companies from biopharmaceuticals to medical devices and healthcare services worldwide private equity orbimeds private equity strategy is broad and flexible investing from startups through growth equity orbimed is typically a lead investor seeking to help build our portfolio companies our geographic focus includes north america asia europe and israel royalty opportunities orbimed provides commercialstage healthcare companies with nondilutive structured debt capital additionally orbimed can monetize royalty streams providing valuable financing solutions to owners of intellectual property firm history to thrive organisms need to adapt and grow so do investment firms through  years of volatile changing investment environments weve embraced new opportunities and expanded our global footprint    orbimeds investment business was founded in new york city    launched our first longshort fund and made our first venture capital investment    launched our first dedicated venture capital fund    opened offices in san francisco and shanghai china    opened office in mumbai india    opened office in herzliya israel    launched our first dedicated royalty  credit fund    hired our th employee our team has helped nurture and commercialize some of todays most successful healthcare companies meet our team insider trading  orbimed capital gp iii llc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  orbimed capital gp iii llc select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm response biomedical corp rbm orbimed advisors llcorbimed capital gp iii llcisaly samuel dorbimed advisors ltdorbimed asia gp lpdirector owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view purchase  pm pieris pharmaceuticals inc pirs orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  iapd  investment adviser search an official website of the united states government individual firm at  miles  miles  miles search below is a list of all possible matches that were returned based on the search criteria you provided search results may include both investment advisers and brokerdealers results show whether each firm is an investment adviser brokerdealer or both clicking the get details button will provide you with a summary for the individual or firm for additional information please see the information below the list of possible matches  result orbimed advisors llccrd   sec  alternate names orbimed advisors india private limited relying adviser  india  orbimed advisors llc  orbimed asia gp ii lp relying adviser  cayman islands  orbimed asia gp iii lp relying adviser  cayman islandsi  orbimed asia gp lp relying adviser  cayman islands  orbimed capital gp i llc relying adviser  delaware  orbimed capital gp ii llc relying adviser  delaware  orbimed capital gp iii llc relying adviser  delaware  orbimed capital gp iv llc relying adviser  delaware  orbimed capital gp v llc relying adviser  delaware  orbimed capital gp vi llc relying adviser  delaware  orbimed capital llc relying adviser  delaware  orbimed global healthcare gp llc relying adviser  delaware  orbimed israel biofund gp limited partnership relying adviser  israel  orbimed israel gp ii lp relying adviser  cayman islands  orbimed israel partners limited relying adviser  israel  orbimed rof ii llc relying adviser  delaware  lexington avenue th floor new york ny  investment adviser firm the investment advisers listed above are or were in the last  years registered with the sec andor the states or exempt from registration but required to file reports with the sec andor the states the brokerdealers listed above have information in finra’s brokercheck system by clicking on any investment adviser above you will be viewing the most recent form adv it filed investment advisers file a form adv to register with the sec andor the states exempt reporting advisers complete a portion of form adv for purposes of reporting to the sec andor the states by clicking on any brokerdealer above you will be linked to finras brokercheck system to view information about that brokerdealer if you would like additional information about an investment adviser such as the investment advisers previously filed form advs contact the sec public reference room  or contact a state where the investment adviser is registered or files reports if the individual or firm you are searching for is not listed above click here for suggestions please click here to return to the beginning of the search results orbimed capital gp iii llc  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors orbimed capital gp iii llc check out list of companies and businesses related to orbimed capital gp iii llc find out orbimed capital gp iii llc address and contact details view other people related to orbimed capital gp iii llc  coworkers colleagues companions etc address  third avenue th fl new york  ny companies related to orbimed capital gp iii llc cikcompany namepositioncompany addressresponse biomedical corp  th avenue w vancouver vppglaukos corp avenida fabricante san clemente complete genomics inc stierlin court mountain view selecta biosciences inc arsenal way watertown roka bioscience inc independence boulevard warren sientra inc south fairview avenue suite  santa barbara pieris pharmaceuticals inc state street th floor boston viewray inc thermo fisher way oakwood village  orbimed capital gp iii llc on the web persons related to orbimed capital gp iii llc  response biomedical corpnamepositioncitywilliam j adamscfo  corporate secretary vancouvertsonis anastasiosvancouvertsonis anastasiosvancouverholler anthonyvancouverholler anthonyvancouverholler anthonyvancouverholler anthonyvancouverrichard canotevancouverseverson clintvancouverseverson clintvancouverseverson clintonvancouverwang davidvancouveranthony holler drvancouveranthony holler drvancouverdavid wang drvancouverdavid wang drvancouverjoseph keegan drvancouverjoseph keegan drvancouverpeter thompson drvancouverpeter thompson drvancouvermorris duanevancouvermorris duanevancouvermorris duanevancouverliming fuhangzhou zhejiang chinahangzhou joinstar medical instrument  reagent co ltdhangzhou zhejiang chinahangzhou lizhu medical instrument  reagent co ltdhangzhou zhejiang chinaanthony f hollerdirector vancouverwebb ianvancouversamuel d isalysamuel d isalynew yorksamuel d isalynew yorkpurvin jeffreyvancouverwang jonathanvancouverkeegan josephvancouverjoseph d keegandirector sunnyvalejoseph d keegansunnyvalejoseph d keegandirector vancouverbarbara kinnairdsteenchief executive officer vancouvershuster lewisvancouvershuster lewisvancouvershuster lewisvancouberkaler livleenvancouverkaler livleenvancouverkaler livleenvancouverpatricia massittivp  admin and corp comm vancouverorbimed advisors llcdirector orbimed advisors llc owner new yorkorbimed advisors ltdnew yorkorbimed advisors ltdnew yorkorbimed advisors ltdnew yorkorbimed asia gp lpnew yorkorbimed asia gp lpnew yorkorbimed asia gp lpnew yorkharris paulvancouverthompson petervancouverthompson petervancouverjeffrey l purvinvancouverbastiani richardvancouverbastiani richardvancouverbear richardvancouverbear richardvancouverbastiani richardvancouverbear richardvancouverkay svancouverkay svancouverkay svancouverclinton seversondirector clinton seversondirector vancouvertimothy patrick shannonvancouvertimothy patrick shannonsrvpworldwidesalesmarketing vancouverlewis shusterdirector san diegolewis shusterdirector vancouverpeter a thompsondirector bellevuepeter a thompsondirector vancouverpatrick toddvancouverpatrick toddvancouverpatrick toddvancouveranastasios tsoniscontroller vancouverdavid wangdirector vancouverjonathan jian wangdirector vancouveradams williamvancouverwenjie xuhangzhou zhejiang chinaxuyi zhouhangzhou zhejiang chinapersons related to orbimed capital gp iii llc  glaukos corpnamepositioncitybrian g atwoodmenlo parkolav bergheimdirector princetongeorge bischofpalo altojames c blairprincetonthomas william burnschief executive officer laguna hillschris m calcaterrachief commercial officer laguna hillsbruce a clevelandsan mateosamuel d colellasanta claraturner danielmenlo parkassociates domainprincetondomain partners iv lp owner princetondomain partners viii lp owner princetonbrian h doveydp iv associates lp owner princetondp viii associates lp owner bostonnathan r everyseattlefhm v llcseattlefhm v lpseattlemark j foleydirector pleasantonalan d frazierseattlefrazier healthcare v lp owner seattlephilip t gianoskliman gilbertmenlo parkjoseph e gilliamcfo svp corporate development san clementemichael b gordonbrian k halakprincetonrichard l harrisoncfo  treasurer patrick j heronpalo altodavid f hoffmeisterdirector carlsbadw stephen holmesmenlo parkinterwest management partners ix llc owner menlo parkinterwest partners ix lpmenlo parksamuel d isalyross a md jaffemenlo parksilverstein jonathannew yorkkim p kamdarprincetonnina s kjellsonmenlo parkgilbert h klimandirector menlo parkwilliam j phd linkdirector santa anabarbara n lubashmenlo parkpaul s maderadirector chapekar manishmenlo parkchapekar manishmenlo parkmeritech capital affiliates iii l ppalo altomeritech capital associates iii llc owner palo altomeritech capital partners iii lppalo altodonald b mildermenlo parkmontreux equity management iv llcsan franciscomontreux equity partners iv lp owner san franciscomontreux iv associates llcsan franciscorobert j moredirector princetonnader j nainiseattlekhaled nasrsan franciscobergheim olavlaguna hillsbergheim olavlaguna hillsorbimed advisors llcdirector arnold l oronskymenlo parkmadera paulpalo altodouglas a peppermenlo parkharrison richardlaguna hillsmore robertmenlo parkmore robertmenlo parkrebecca b robertsonkathleen k schoemakerprincetonjonathan silversteindirector new yorkmarc stapleydirector san diegoburns thomaslaguna hillsjames n topperseattlejesse i treuprincetonversant affiliates fund ia lpmenlo parkversant affiliates fund ib lpmenlo parkversant side fund i lpmenlo parkversant venture capital i lpmenlo parkversant ventures i llc owner menlo parknicole vitullorichmondrob wardpalo altoaimee s weisnerdirector santa analink williamnewport beachpersons related to orbimed capital gp iii llc  complete genomics incnamepositioncitybarkas phd alexanderpalo altosenyei md andrewla jollaajay bansalmountain viewajay bansalchief financial officer mountain viewajay bansalsvp  chief financial officer mountain viewalexander e barkasdirector palo altoc thomas caskeydirector mountain viewc thomas caskeydirector mountain viewwaite jr charleskirklandreid cliffordmountain viewjames d dondero owner dallasradoje t drmanacmountain viewradoje t drmanacchief scientific officer mountain viewradoje t drmanacchief scientific officer mountain viewenterprise partners management llc owner la jollaenterprise partners v l p owner la jollaenterprise partners vi lp owner la jollaessex woodlands health ventures fund viiia lpthe woodlandsessex woodlands health ventures fund viiib lpthe woodlandsessex woodlands health ventures fund viii lp owner the woodlandscarl l gordondirector new yorkhighland capital management lpdallashighland capital management lp owner dallashighland capital management lpdallashighland capital management services incdallasarthur w homansvp gen counsel  secretary mountain viewsamuel d isalysamuel d isalynew yorkbruce k martinmountain viewbruce k martinsvp of product development mountain viewbruce k martinsvp product development mountain viewbruce k martinsvp product development mountain vieworbimed advisors llc owner new yorkorbimed advisors llc owner new yorkovp venture partners vi lp owner kirklandovp venture partners vi lp owner kirklandovp vi entrepreneurs fund lpkirklandprospect management co iii llcpalo altoprospect venture partners iii l p owner palo altokeith raffelsvp  chief commercial officer mountain viewclifford a reidmountain viewclifford a reidchief executive officer mountain viewclifford a reidpresident  ceo mountain viewcurson robertmountain viewandrew e senyeidirector la jollalewis shusterdirector mountain viewlewis shusterdirector mountain viewstrand advisors incdallasstrand advisors incdallasmark j sutherlandmountain viewmark j sutherlandsvp business development mountain viewcharles p waite jrdirector kirklandcharles p waite jrdirector kirklandcharles p waite jrkirklandrobert t walldirector greenwood villagerobert t walldirector greenwood villagepersons related to orbimed capital gp iii llc  selecta biosciences incnamepositioncitydavid abrahamgc and corporate secretary watertownnoubar afeyanlexingtonnashat amirwatertownnashat amirwatertownnashat amirwatertownsallin aymericwatertownsallin aymericwatertownsallin aymericwatertowntimothy c barabedirector woburngordon carlwatertowngordon carlwatertowngordon carlwatertownwerner cautreelspresident and ceo woburndouglas colewatertownabraham davidwatertownabraham davidwatertownsiewers davidwatertownsiewers davidwatertownsiewers davidwatertowncole douglaswatertownsands earlwatertownsands earlwatertownkania jr edwinwatertownkania jr edwinwatertownomid farokhzaddirector cambridgeflagship ventures  general partner llccambridgeflagship ventures fund  lp owner cambridgesiber georgewatertownsiber georgewatertowncarl l gordondirector new yorkpeter barton huttdirector irvinesamuel d isalylloyd p johnstoncoo  senior vp rd watertownedwin m kania jrdirector cambridgepeter kellerchief business officer watertowntakashi kei kishimotochief scientific officer watertownrobert langerleukon investments lpchestnut hillshaydullina leysanwatertownjohnston lloydwatertownjohnston lloydwatertownlimited partnership nanodimensiongrand caymannanodimension management ltd owner grand caymanamir nashatdirector san diegofarokhzad omidwatertownfarokhzad omidwatertownfarokhzad omidwatertownorbimed advisors llcdirector osage partners llcbala cynwydosage university gp ii lpbala cynwydosage university partners ii lp owner bala cynwydzenner patrickwatertownhutt peterwatertownhutt peterwatertownhutt peterwatertownkeller peterwatertownkeller peterwatertownpolaris venture management co v llc owner walthampolaris venture partners entrepreneurs fund v lpwalthampolaris venture partners founders fund v lpwalthampolaris venture partners special founders fund v lpwalthampolaris venture partners v lpwalthambratzler robertwatertownlanger robertwatertownlanger robertwatertownlanger jr robertwatertownrusnano owner moscowaymeric sallindirector watertownearl sandschief medical officer watertownselecta rkfn ltdmoscowleysan shaydullinawatertowndavid siewerscfo and treasurer watertowntimothy a springerdirector chestnut hillkishimoto takashiwatertownkishimoto takashiwatertowntas partners llcdirector chestnut hillbarabe timothywatertownspringer timothywatertownandrian ulrich vonwatertowncapital ibf netherlands bv vtb owner moscowcautreels wernerwatertowncautreels wernerwatertowncautreels wernerwatertownudaltsov yuriywatertownudaltsov yuriywatertownpatrick j zennerdirector persons related to orbimed capital gp iii llc  roka bioscience incnamepositioncitym james barrettdirector baltimorem james barrettdirector timoniumpeter j barris owner baltimorepeter j barris owner timoniumforest baskett owner baltimoreforest baskett owner timoniumjoshua h bilenkerwarrenlars boesgaardvice president cfo bedforddavid bondermandavid bondermanfort worthdavid bondermanfort worthfred e cohendirector san franciscofred e cohenfort worthjames g coulterforth worthjames g coulterfort worthjames g coulterfort worthmcgirr davidwarrenmichael p doyledirector warrenryan d drant owner timoniumcohen fredwarrensamuel d isalysamuel d isalynew yorksamuel d isalynew yorkbarret phd jimwarrensilverstein jonathanwarrenbilenker md joshwarrenpatrick j kerins owner baltimorepatrick j kerins owner timoniumkrishna kittu kolluri owner baltimorekrishna kittu kolluri owner timoniumboesgaard larswarrenbeth duseau maryceo and president hatfieldamyjo mccardellsenior vice president warrendavid w j mcgirrdirector greenwichdavid w j mcgirrdirector warrenwatts michaelwarrendoyle michaelwarrendavid m mott owner gaithersburgdavid m mott owner timoniumwalter m narajowskisenior vp  general manager warrennea  gp ltdtimoniumpartners  limited partnership neatimoniumnew enterprise associates  lp owner timoniumvaleriani nicholaswarrenorbimed advisors llcdirector orbimed advisors llcnew yorkorbimed advisors llc owner new yorkthomas paulsan diegothomas paulwarrenthomas paulwarrenscott d sandell owner baltimorescott d sandell owner timoniumjonathan silversteindirector new yorkjonathan silversteinwarrenjonathan silversteindirector warrensteven sobieskisvp  chief financial officer steven sobieskisvp  chief financial officer warrensobieski stevenwarrensobieski stevensan diegosobieski stevenwarrenpaul thomaspresident and ceo branchburgpaul thomaspresident and ceo warrentpg group holdings sbs advisors inc owner fort worthtpg group holdings sbs advisors inc owner fort worthtpg group holdings sbs advisors incfort worthnicholas j valerianidirector new brunswickravi viswanathan owner timoniumharry r weller owner baltimoreharry r weller owner timoniumpersons related to orbimed capital gp iii llc  sientra incnamepositioncityllp abingworth owner londonclarus lifesciences i lpcambridgeclarus ventures i llccambridgeclarus ventures i management lpcambridgenicholas galakatosbostonr scott greerdirector r scott greersanta barbararishi guptasanta barbaratimothy hainesdirector londontimothy hainesdirector londonzeini hanisanta barbaradennis hennersouth san franciscocharles huinercoo  svp corp dev strategy santa barbarasamuel d isalysamuel d isalynew yorksmith joelsanta barbararobert liptakbostonpigeon matthewsanta barbarapark michelesouth san franciscosimon nicksouth san franciscojeffrey m nugentchief executive officer san mateojeffrey m nugentsanta barbarakevin c oboyledirector san diegokevin c oboylesanta barbaraorbimed advisors llc owner orbimed advisors llcnew yorkmatthew pigeoncfo and treasurer santa barbaragupta rishinew yorkadelman robertnew yorkphilippe schaisondirector dublin nicholas simondirector cambridgenicholas simonsanta barbarajoel s smithsanta barbarakurt wheelerbostonpatrick f williamspleasantonhani m zeinidirector santa barbarahani m zeinisanta barbarapersons related to orbimed capital gp iii llc  pieris pharmaceuticals incnamepositioncityjulian adamsdirector cambridgejeanpierre bizzaridirector san diegokhuong chaubostonkhuong chaufreisingweihenstephantakke christinafreisingweihenstephandeptulahicks darlenebostondeptulahicks darlenefreisingweihenstephandarlene m deptulahickssvp chief financial officer wakefieldjames a geraghtydirector framinghamsamuel d isalybizzari jeanpierrebostonchau quang khuongdirector san diegochristopher p kiritsydirector claude knopfchief business officer bostonlouis matissee remarks freisingweihenstephanrichman michaelfreisingweihenstephanrichman michaelbostonorbimed advisors llcdirector steven prelackdirector newtonmichael richmandirector germantownyoder stephenfreisingweihenstephanyoder stephenbostonprelack stevenfreisingweihenstephanprelack stevenbostonchristina takkefreisingweihenstephanlance e thibaultreykjavikstephen s yoderchief executive officer freisingweihenstephanpersons related to orbimed capital gp iii llc  viewray incnamepositioncitypuri adityaoakwood villageaisling capital ii lpnew yorkaisling capital partners llcnew yorkaisling capital partners lpnew yorkbansal ajayoakwood villagebansal ajayoakwood villageajay bansalchief financial officer san carlosjoshua h bilenkerdirector warrendavid p bonitadirector san diegomichael brandtoakwood villageroberts brianoakwood villageroberts brianoakwood villagecastelein caleyoakwood villagecaley casteleindirector grand prairied david chandleroakwood villageraanes chrisoakwood villagedavid chandler doakwood villagedavid chandler doakwood villagebonita davidoakwood villagejames f dempseychief scientific officer oakwood villagekeare douglasoakwood villagesteve elmschesterfmr corp owner bostonmark stephen golddirector alachuamckinnell jr henryoakwood villagemckinnell jr henryoakwood villagesamuel d isalydempsey jamesoakwood villagebilenker joshuaoakwood villagebilenker joshuaoakwood villagedouglas kearechief operating officer oakwood villagegold markoakwood villagehenry a mckinnelldirector brandt michaeloakwood villagecogswell michaeloakwood villageorbimed advisors llcdirector puissance capital fund gp llcnew yorkpuissance capital management gp llcnew yorkpuissance capital management lpnew yorkpuissance crossborder opportunities i lpnew yorkdennis j purcellnew yorkaditya puridirector kuala lumpurm malaysiachris raanespresident and ceo sunnyvalebrian k robertsdirector bostondr drew schiffnew yorkwang theodoreoakwood villagetheodore t wangdirector new york potentially same personnamecitycountryorbimed capital gp iii llcnew yorknyorbimed capital gp iii llcnew yorknyorbimed capital gp iii llcnew yorknyorbimed capital gp iii llcnew yorknyorbimed capital gp iii llcnew yorknyorbimed capital gp iii llcnew yorkny orbimed capital gp iii llc top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active orbimed capital gp iii llc • new york ny how do i update this listing orbimed capital gp iii is based out of new york whalewisdom has at least  dg filings in our database for orbimed capital gp iii summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from orbimed capital gp iii llc enter your email address below and choose submit your email cancel contact info orbimed capital gp iii llc  lexington avenue new york ny     business phone  recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  current dg holdings stock sector shares held market value rank source source date nxstage medical inc nxtm health care    d  athersys inc athx health care    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free insider trading  orbimed advisors llc  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  orbimed advisors llc select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm loxo oncology inc loxo orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view sale  pm glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view purchase  pm audentes therapeutics inc bold orbimed advisors llcdirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm response biomedical corp rbm orbimed advisors llcorbimed capital gp iii llcisaly samuel dorbimed advisors ltdorbimed asia gp lpdirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm adaptimmune therapeutics plc adap orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector    indirect view purchase  pm intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector    indirect view purchase  pm corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm otonomy inc otic orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view purchase  pm dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner    indirect view purchase  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view sale  pm sientra inc sien orbimed advisors llcorbimed capital gp iii llcisaly samuel d owner    indirect view purchase  pm pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector    indirect view purchase  pm pieris pharmaceuticals inc pirs orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner    indirect view sale  pm relypsa inc rlyp orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view sale  pm intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view sale  pm intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector    indirect view purchase  pm mirati therapeutics inc mrtx orbimed advisors llcorbimed capital gp iv llcisaly samuel d owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view other  pm nana response biomedical corp rbm orbimed advisors llcorbimed advisors ltdisaly samuel dorbimed asia gp lporbimed capital gp iii llcdirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm nana roka bioscience inc roka orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view purchase  pm  viewray inc vray orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana audentes therapeutics inc bold orbimed advisors llcdirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana selecta biosciences inc selb orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana intellia therapeutics inc ntla orbimed advisors llcorbimed capital gp v llcorbimed global healthcare gp llcisaly samuel ddirector   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana corvus pharmaceuticals inc crvs orbimed advisors llcdirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view conversion  pm nana dimension therapeutics inc dmtx orbimed advisors llcorbimed capital gp v llcisaly samuel ddirector owner   indirect view option award  pm nana intercept pharmaceuticals inc icpt orbimed advisors llcorbimed capital gp iv llcisaly samuel ddirector   indirect view conversion  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view other  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view conversion  pm nana pronai therapeutics inc dnai orbimed advisors llcisaly samuel dorbimed private investments v lpdirector   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view tax withholding  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view conversion  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view exercise  pm nana glaukos corp gkos orbimed advisors llcorbimed capital gp iii llcisaly samuel ddirector owner   indirect view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  orbimed advisors llc sc da filing concerning afmd on  whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active schedule da filed by orbimed advisors llc total shares  subject company affimed nv  view complete ownership history backtest filed as of date  event date  overall  ownership  reporting persons name solevoting power sharedvoting power soledispositive power shareddispositive power aggregateamount owned percentof class orbimed advisors llc       orbimed capital gp iii llc       samuel d isaly       view original filing on edgars raw filing contents txt   hdrsgml    accession number  conformed submission type sc da public document count  filed as of date  date as of change  group members orbimed capital gp iii llc group members samuel d isaly subject company company data company conformed name affimed nv central index key  standard industrial classification pharmaceutical preparations  irs number  state of incorporation m fiscal year end  filing values form type sc da sec act  act sec file number  film number  business address street  im neuenheimer feld   city heidelberg state m zip  business phone  mail address street  im neuenheimer feld   city heidelberg state m zip  former company former conformed name affimed therapeutics bv date of name change  filed by company data company conformed name orbimed advisors llc central index key  irs number  state of incorporation de filing values form type sc da business address street   lexington avenue street  th floor city new york state ny zip  business phone   mail address street   lexington avenue street  th floor city new york state ny zip  sc da  ssscdahtm amendment no      united states securities and exchange commission washington dc       schedule d under the securities exchange act of  amendment no       affimed nv name of issuer      common stock title of class of securities      n cusip number      orbimed advisors llc orbimed capital gp iii llc samuel d isaly       lexington avenue th floor new york ny  telephone    name address and telephone number of person authorized to receive notices and communications      january   date of event which requires filing of this statement      if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of § de df or dg check the following box £      note  schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits  see § db for other parties to whom copies are to be sent      the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page      the information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of  “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes              of    cusip no  n                 name of reporting persons           orbimed advisors llc  check the appropriate box if a member of a group see instructions                       a o b o  sec use only                            source of funds see instructions           na  check box if disclosure of legal proceedings is required pursuant to items d or e                     o  citizenship or place of organization           delaware number of shares beneficially owned by each reporting person with  sole voting power              shared voting power             sole dispositive power             shared dispositive power              aggregate amount beneficially owned by each reporting person                  check box if the aggregate amount in row  excludes certain shares see instructions                                                     o  percent of class represented by amount in row                        †  type of reporting person see instructions                    ia   includes  shares that may be transferred pursuant to the carveout agreements described in item  † this percentage is calculated based upon  shares of the issuer’s common stock as defined below outstanding as set forth in the issuer’s prospectus supplement filed with the securities and exchange commission the “sec” on january       of    cusip no  n                 name of reporting persons                           orbimed capital gp iii llc  check the appropriate box if a member of a group see instructions                                                              a o b o  sec use only                                          source of funds see instructions                       na  check box if disclosure of legal proceedings is required pursuant to items d or e                                                                    o  citizenship or place of organization                         delaware number of shares beneficially owned by each reporting person with  sole voting power                                 shared voting power                              sole dispositive power                         shared dispositive power                           aggregate amount beneficially owned by each reporting person                        check box if the aggregate amount in row  excludes certain shares see instructions                                                     o  percent of class represented by amount in row                                †  type of reporting person see instructions                                   oo   includes  shares that may be transferred pursuant to the carveout agreements described in item  † this percentage is calculated based upon  shares of the issuer’s common stock as defined below outstanding as set forth in the issuer’s prospectus supplement filed with the securities and exchange commission the “sec” on january     of       cusip no  n                 name of reporting persons                            samuel d isaly  check the appropriate box if a member of a group see instructions                                                     a o b o  sec use only                                                 source of funds see instructions                       na  check box if disclosure of legal proceedings is required pursuant to items d or e                                                o  citizenship or place of organization                         united states number of shares beneficially owned by each reporting person with  sole voting power                                shared voting power                             sole dispositive power                                   shared dispositive power                             aggregate amount beneficially owned by each reporting person                             check box if the aggregate amount in row  excludes certain shares see instructions                                                 o  percent of class represented by amount in row                       †  type of reporting person see instructions                       in   includes  shares that may be transferred pursuant to the carveout agreements described in item  † this percentage is calculated based upon  shares of the issuer’s common stock as defined below outstanding as set forth in the issuer’s prospectus supplement filed with the securities and exchange commission the “sec” on january       of       item   security and issuer   this amendment no  to schedule d supplements and amends the statement on schedule d of orbimed advisors llc orbimed capital gp iii llc and samuel d isaly originally filed with the securities and exchange commission the “sec” on september   the “statement” and amended by amendment no  thereto filed with the sec on february   amendment no  filed on may   amendment no  filed on august   amendment no  filed on march   amendment no  filed on march   and amendment no  filed on september    the statement relates to the common stock nominal value € per share the “common stock” of affimed nv formerly affimed therapeutics bv a public company with limited liability naamloze vennootschap organized under the laws of the netherlands the “issuer” with its principal executive offices located at im neuenheimer feld   heidelberg germany  the common stock is listed on the nasdaq global market under the ticker symbol “afmd”  information given in response to each item shall be deemed incorporated by reference in all other items as applicable   on january   the issuer closed a registered direct offering announced on january    the issuer issued in the offering a total of  shares of common stock at a purchase price of  per share of common stock “shares” with gross proceeds of approximately  the “share issuance”  as a result of the share issuance the issuer’s total number of outstanding shares increased to  the “outstanding share increase”  none of the reporting persons participated in the offering  as a result of the share issuance and more specifically the outstanding share increase the percentage of outstanding shares that the reporting persons may be deemed to beneficially own was reduced by more than one percent of the issuer’s shares outstanding since the filing of amendment no  to the statement   item   identity and background   a           this amendment no  to the statement is being filed by orbimed advisors llc “advisors” a limited liability company organized under the laws of delaware orbimed capital gp iii llc “gp iii” a limited liability company organized under the laws of delaware and samuel d isaly “isaly” an individual collectively the “reporting persons”   b – c advisors a registered investment adviser under the investment advisers act of  as amended is the sole general partner of associates iii and the sole managing member of gp iii which is the sole general partner of opi iii  opi iii and associates iii hold shares as more particularly described in item  below  advisors has its principal offices at  lexington avenue th floor new york new york    gp iii has its principal offices at  lexington avenue th floor new york new york    isaly a natural person owns a controlling interest in advisors   the directors and executive officers of advisors and gp iii are set forth on schedules i and ii attached hereto  schedules i and ii set forth the following information with respect to each such person   i name   ii business address   iii present principal occupation or employment and the name principal business and address of any corporation or other organization in which such employment is conducted   iv citizenship   d – e during the last five years neither the reporting persons nor any person named in schedule i or ii have been i convicted in a criminal proceeding excluding traffic violations or similar misdemeanors or ii a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment decree or final order enjoining future violations of or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws   f isaly is a citizen of the united states     of       item   source and amount of funds or other consideration   not applicable   item   purpose of transaction   not applicable  as described more fully in item  above the event giving rise to the obligation of the reporting persons to file this amendment no  did not involve any transactions effected by one or more reporting persons with respect to the shares  the shares initially had been acquired and those that continue to be held are held by the reporting persons for the purpose of making an investment in the issuer and not with the intention of acquiring control of the issuer’s business   the reporting persons from time to time intend to review their investment in the issuer on the basis of various factors including the issuer’s business financial condition results of operations and prospects general economic and industry conditions the securities markets in general and those for the issuer’s common stock in particular as well as other developments and other investment opportunities  based upon such review the reporting persons will take such actions in the future as the reporting persons may deem appropriate in light of the circumstances existing from time to time  if the reporting persons believe that further investment in the issuer is attractive whether because of the market price of the common stock or otherwise they may acquire shares or other securities of the issuer either in the open market or in privately negotiated transactions  similarly depending on market and other factors the reporting persons may determine to dispose of some or all of the shares currently owned by the reporting persons or otherwise acquired by the reporting persons either in the open market or in privately negotiated transactions   except as set forth in this amendment no  to the statement the reporting persons have not formulated any plans or proposals which relate to or would result in  a the acquisition by any person of additional securities of the issuer or the disposition of securities of the issuer b an extraordinary corporate transaction such as a merger reorganization or liquidation involving the issuer or any of its subsidiaries c a sale or transfer of a material amount of the assets of the issuer or any of its subsidiaries d any change in the present board of directors or management of the issuer including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board e any material change in the issuer’s capitalization or dividend policy of the issuer f any other material change in the issuer’s business or corporate structure g any change in the issuer’s charter or bylaws or other instrument corresponding thereto or other action which may impede the acquisition of control of the issuer by any person h causing a class of the issuer’s securities to be deregistered or delisted from a national securities exchange or to cease to be authorized to be quoted in an interdealer quotation system of a registered national securities association i a class of equity securities of the issuer becoming eligible for termination of registration pursuant to section g of the act or j any action similar to any of those enumerated above   item   interest in securities of the issuer   ab   as of the date of this filing advisors gp iii and isaly may be deemed for purposes of rule d of the act directly or indirectly including by reason of their mutual affiliation to be the beneficial owners of the common stock described in item  below  based upon information contained in the most recent available filing by the issuer with the sec such common stock deemed to be indirectly beneficially owned by gp iii constitutes approximately  of the issued and outstanding common stock and such common stock deemed to be indirectly beneficially owned by advisors and isaly constitutes approximately  of the issued and outstanding common stock  advisors pursuant to its authority as the sole managing member of gp iii which is the sole general partner of opi iii and as the sole general partner of associates iii may be deemed to indirectly beneficially own the common stock held by opi iii and associates iii  gp iii pursuant to its authority as the general partner of opi iii may be deemed to indirectly beneficially own the common stock held by opi iii  isaly pursuant to his authority as the managing member of advisors and owner of a controlling interest in advisors pursuant to its limited liability company agreement may be deemed to also indirectly beneficially own the common stock attributable to advisors  as a result isaly advisors and gp iii share the power to direct the vote and the disposition of the shares held by opi iii described in item  below and isaly and advisors share the power to direct the vote and the disposition of the shares held by associates iii described in item  below          of         in addition advisors and gp iii pursuant to their authority under the limited partnership agreements of opi iii andor associates iii as more particularly referred to in item  below prior to the date of this filing caused opi iii and associates iii as applicable together with certain other shareholders of the issuer collectively with opi iii and associates iii the “selling shareholders” to enter into agreements substantially in the form filed as exhibit  to amendment no  to the statement the “amended and restated carveout agreements” with the issuer’s managing directors and certain of the issuer’s supervisory directors and consultants the “beneficiaries” as described in item  below   c   seller date of transaction transaction number of shares price per share opi iii january   sold   associates iii january   sold     except as disclosed above the reporting persons have not effected any transactions in the shares during the past sixty  days   d not applicable   e not applicable   item   contracts arrangements understandings or relationship with respect to securities of the issuer   in addition to the relationships between the reporting persons described in items   and  above gp iii is the sole general partner of opi iii pursuant to the terms of the limited partnership agreement of opi iii  advisors is the sole managing member of gp iii pursuant to the terms of the limited liability company agreement of gp iii and the sole general partner of associates iii pursuant to the terms of the limited partnership agreement of associates iii  pursuant to these agreements and relationships advisors and gp iii have discretionary investment management authority with respect to the assets of opi iii and advisors has discretionary investment management authority with respect to the assets of associates iii  such authority includes the power of gp iii and advisors to vote and otherwise dispose of securities purchased by opi iii and the power of advisors to vote and otherwise dispose of securities purchased by associates iii  the number of outstanding shares held of record by opi iii is  and the number of outstanding shares held of record by associates iii is   advisors and isaly may be considered to hold indirectly  shares and gp iii may be considered to hold indirectly  shares   on june   michael b sheffery a partner emeritus of advisors retired from the board of directors of the issuer at the expiration of his term      registration rights agreement   the issuer is party to a registration rights agreement among opi iii associates iii sgr sagittarius holding ag biomed invest i ltd lsp iii omni investment coöperatief ua and novo nordisk as dated september   the “registration rights agreement” a summary of which is set forth at item  of amendment no  to the statement  all of the shares held by opi iii and associates iii with the exception of the shares covered by the amended and restated carveout agreements were registered on the f registration statement   amended and restated carveout agreements   in connection with the issuer’s initial public offering advisors and gp iii pursuant to their authority under the limited partnership agreements of opi iii andor associates iii caused opi iii and associates iii as applicable together with the other selling shareholders to enter into the carveout agreements with the beneficiaries described in the statement the “original carveout agreements”  on february   the selling shareholders entered into a termination agreement pursuant to which the selling shareholders and the beneficiary agreed to terminate the original carveout agreement with such beneficiary for the future and to replace it by individual amended and restated carveout agreements between each selling shareholder and the beneficiary     of       the amended and restated carveout agreements grant each beneficiary the right to receive a payment equal to a certain percentage of the fair value of the issuer contingent upon the occurrence of a defined event including an initial public offering  following the expiration of applicable lockup agreements i the obligations of opi iii and associates iii under the amended and restated carveout agreements are satisfied through a transfer to the beneficiaries of an amount of shares of common stock in the aggregate amount of  shares and ii portions of these shares are sold pursuant to rule  to satisfy withholding taxes triggered by the transfer and delivered to the beneficiaries with the net amount of shares to which each beneficiary is entitled to receive pursuant to his or her individual amended and restated carveout agreement   the foregoing description of the amended and restated carveout agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the form of amended and restated carveout agreement a copy of which was filed as exhibit  to amendment no  to the statement and is incorporated herein by reference  other than as described in this amendment no  to the statement to the best of the reporting persons’ knowledge there are no other contracts arrangements understandings or relationships legal or otherwise among the persons named in item  and between such persons and any person with respect to any securities of the issuer   item   materials to be filed as exhibits   exhibit description  joint filing agreement among orbimed advisors llc orbimed capital gp iii llc and samuel d isaly  form of registration rights agreement incorporated by reference to exhibit  to amendment no  to the issuer’s form f sec file no  filed with the sec on july    form of amended and restated carveout agreement incorporated by reference to exhibit  to amendment no  to the reporting persons’ statement on schedule d filed with the sec on february                  of       signature      after reasonable inquiry and to the best of each of the undersigned’s knowledge and belief each of the undersigned certifies that the information set forth in this amendment no  to the statement is true complete and correct      dated  january       orbimed advisors llc             by   s samuel d isaly       name samuel d isaly       title managing member                         orbimed capital gp iii llc             by orbimed advisors llc     its managing member                       by   s samuel d isaly       name samuel d isaly       title managing member                         samuel d isaly             by   s samuel d isaly       name samuel d isaly                          of       schedule i   the name and present principal occupation of each of the executive officers and directors of orbimed advisors llc are set forth below  unless otherwise noted each of these persons are united states citizens and have as their business address  lexington avenue th floor new york ny    name position with reporting person principal occupation samuel d isaly managing member managing member     orbimed advisors llc carl l gordon member member     orbimed advisors llc sven h borho member member german and swedish citizen   orbimed advisors llc jonathan t silverstein member member     orbimed advisors llc w carter neild member member     orbimed advisors llc geoffrey c hsu member member     orbimed advisors llc evan d sotiriou chief financial officer chief financial officer     orbimed advisors llc                       of       schedule ii           the business and operations of orbimed capital gp iii llc are managed by the executive officers and directors of its managing member orbimed advisors llc set forth on schedule i attached hereto                                of       exhibit index   exhibit description  joint filing agreement among orbimed advisors llc orbimed capital gp iii llc and samuel d isaly  form of registration rights agreement incorporated by reference to exhibit  to amendment no  to the issuer’s form f sec file no  filed with the sec on july    form of amended and restated carveout agreement incorporated by reference to exhibit  to amendment no  to the reporting persons’ statement on schedule d filed with the sec on february                          elevate your investments try it for free ﻿ insider trade orbimed advisors llc unloaded  shares of sientra inc nasdaqsien – octafinance thursday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated insider trade orbimed advisors llc unloaded  shares of sientra inc nasdaqsien  by octastaff in insider news share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called insider trade orbimed advisors llc unloaded  shares of sientra inc nasdaqsien and is was published by octafinancecom at httpwwwoctafinancecominsidertradeorbimedadvisorsllcunloadedsharesofsientraincnasdaqsiencaptchasubmit orbimed advisors llc insider buy transaction orbimed advisors llc – а brainy insider in sientra inc nasdaqsien    – made a sale of  shares of sientra inc worth   based on an average stock price per share of   at present orbimed advisors llc owns  shares or  of the company’s total market capitalization a filing documented published october   with the washingtonbased security and exchange commission revealed here shows full details for the trade sientra inc stock rating sentiment and fundamentals the four analysts expect  earnings per share for  which translates into a price to earnings ratio of exactly nan for the stock exchange listed company they expect sientra inc to grow at yearoveryear rate of  rating  sentimentpsychsignal socialsellanalysts ratingbuyhedge funds sentimentbuy stock fundamentalsearnings  fcf trendbuysectorindustry macrobullishvaluation models technical analysisst trenddownmt trenddownlt trenddown octafinance ratingsell  read how our stock ratings system works we rate sientra inc “sell” not just because of orbimed advisors llc’s informed stock sell but also because our time momentum model says so sientra inc’s stock is in a bearish trend going down around  in the last  days price chart of sientra nasdaqsien stock source rightedgesystems yahoo split  dividend adjusted data and octafinance interpretations popular stock traders who also include david tepper once claimed that the highest riskadjusted returns are made when technical and fundamental analysis are combined hedge funds ownership recently released f public filings reveal  hedge funds and institutional investors owned shares of sientra inc the institutional ownership of the company in the last quarter is high at  of the shares outstanding they increased by  the total shares they hold as of that quarter these institutional investors owned  million shares as disclosed by sec’s f filings the stock is in top  stock portfolios of four registered investment advisors these funds are abingworth llp clarus ventures llc pura vida investments llc drill craig a abingworth llp is the most bullish institutional investor on sientra inc with ownership of  million shares as of q  for  of the fund’s portfolio clarus ventures llc is another bullish player possessing  million shares of the company or  of their stocks portfolio the new yorkbased fund pura vida investments llc have  of their stock portfolio invested in the company for  shares in addition drill craig a disclosed it had acquired a stake worth  of the fund’s stock portfolio in the company the new yorkbased fund consonance capital management lp was also a notable supporter of the stock with ownership of  shares sientra inc is  of the fund’s stock portfolio sientra nasdaqsien company profile sientra inc is a medical aesthetics company the company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures which it offers in over  variations of shapes sizes and textures the company sells its breast implants and breast tissue expanders or breast products to plastic surgeons the company offers a range of breast implants including anatomicallyshaped textured round textured and round smooth it also offers a line of breast tissue expanders most of which are marketed as acx in  different shapes and sizes that include single and double chamber tissue expanders in addition it offers a range of other aesthetic products including body contouring and other implants silicone elastomer oval carving blocks scar management specialty products temporary singleuse salinefilled breast sizers and nonbreast tissue expanders company website sientra sientra inc was founded in delaware on  the company has  employees as of writing its market worth is  million and it has  million shares outstanding now the company has  shareholders and the institutional ownership is  the stock closed at  yesterday and it had average  days volume of  shares it is down from the  days average shares volume of  sientra inc has a  days low of  and a  weeks high of  the stock price is below the  days simple moving average sientra inc last issued its quarterly earnings stats on  the company reported  eps for the quarter above the consensus estimate of  by  the company had a revenue of  million for  and  million for  therefore the revenue was  million up orbimed advisors llc is also director of pronai therapeutics inc intercept pharmaceuticals inc pieris pharmaceuticals inc glaukos corp anthera pharmaceuticals inc amarin corp plcuk nxstage medical inc biodel inc insulet corp volcano corp avanir pharmaceuticals inc given imaging ltd euthymics bioscience inc orphan medical inc memory pharmaceuticals corp  percent owner of relypsa inc mirati therapeutics inc otonomy inc loxo oncology inc roka bioscience inc response biomedical corp ambit biosciences corp supernus pharmaceuticals inc complete genomics inc pacira pharmaceuticals inc chemocentryx inc athersys inc  new kun run biotechnology inc aryx therapeutics inc cryocor inc aerogen inc lifecell corp orthovita inc  these shares are held of record by orbimed private investments iii – lp “opi iii” orbimed capital gp iii llc “gp iii” is the general partner of opi iii – and orbimed advisors llc “advisors” is the managing member of gp iii samuel d isaly “isaly” – a natural person – is the managing member of and owner of a controlling interest in advisors by virtue of such relationships – gp iii – advisors and isaly may be deemed to have voting and investment power over the securities held by opi iii and as a result may be deemed to have beneficial ownership over such securities  these shares are held of record by orbimed associates iii – lp “associates iii” advisors is the general partner of associates iii isaly is the managing member of and owner of a controlling interest in advisors by virtue of such relationships – advisors and isaly may be deemed to have voting and investment power over the securities held by associates iii and as a result may be deemed to have beneficial ownership over such securities  this report on form  is jointly filed by gp iii – advisors – and isaly each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of rule aa under the securities exchange act of  – as amended the “exchange act” – except to the extent of its or his pecuniary interest therein – if any this report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of section  of the exchange act – or for any other purpose sientra  receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged orbimed advisors llcsientra  nasdaqsien why louis bianco unloaded  stock of cti biopharma corp nasdaqctic anglo american plc lonaal’s chairman and ceo douglas parker unloaded  shares of the company sientra  get news  ratings daily enter your email address below to get the latest news and analysts ratings for sientra with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility d filing orbimed advisors and viewray inc vray  insider monkey companies  see all hedge funds  see all insiders  see all institutional investors  see all click here to see all results for sorry no results has been found matching your query adblocker detected dear valued visitor we have noticed that you are using an ad blocker software although advertisements on the web pages may degrade your experience our business certainly depends on them and we can only keep providing you highquality research based articles as long as we can display ads on our pages to view this article you can disable your ad blocker and refresh this page or simply login we only allow registered users to use ad blockers you can sign up for free by clicking here or you can login if you are already a member hedge funds d filing orbimed advisors and viewray inc vray published on march   at  pm by insider monkey staff in hedge funds page  of next gtgt you can access the original sec filing by clicking here ownership summary table name sole voting power shared voting power sole dispositive power shared dispositive power aggregate amount owned power percent of class orbimed advisors       orbimed capital gp iii       samuel d isaly       samuel isalyorbimed advisors page  of  – sec filing   united statessecurities and exchange commissionwashington dc                            schedule d under the securities exchange act of  amendment no  viewray inc name of issuer common stock title of class of securities l cusip number orbimed advisors llcorbimed capital gp iii llcsamuel d isaly lexington avenue th floornew york ny telephone    name address and telephone number of personauthorized to receive notices and communications march   date of event which requires filing of this statement if the filing person has previously filed a statement on schedule g to report the acquisition that is the subject of this schedule d and is filing this schedule because of § de df or dg check the following box ☐ note schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits  see § db for other parties to whom copies are to be sent the remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page the information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section  of the securities exchange act of  “act” or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act however see the notes follow viewray incfollow viewray inc trade vray now page  of next gtgt related insider monkey articlesd filing starboard value lp and tribune media co nysetrcod filing venbio select advisor and immunomedics inc nasdaqimmud filing waud capital partners ii lp and acadia healthcare company incd filing krensavage asset management llc and rti surgical inc nasdaqd filing magnolia capital fund lp and nicholas financial inc nasdaqnickd filing fir tree and ecostim energy solutions inc nyseeses hedge fund nasdaqvray orbimed advisors sec d filing viewray inc insider monkey small cap strategy download a free copy of our newsletter and see the details inside hedge fund resource center how to beat the market by  percentage points why track hedge funds download a free edition why you should dump your hedge funds  things you didnt know about hedge funds billionaire hedge funds warren buffett berkshire hathaway  david einhorn greenlight capital  george soros soros fund management  t boone pickens bp capital  jim simons renaissance technologies  leon cooperman omega advisors  carl icahn icahn capital lp  steve cohen point asset management  john paulson paulson  co  david tepper appaloosa management lp  about us contact us terms of use privacy policy next post home hedge funds markets blog authors about us contact us privacy policy terms of use site map all text and design is copyright  koala guide llc all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft orbimed capital llc  money az  web results aol search skip over navigation search the web web images images get started on your llc today  simple  reliable process ad · wwwlegalzoomcom​llc start a limited liability company safeguard your personal assets how to start an llc llc pricing packages llc or corporation llc faqs set up an llc  get your business going today  incorporatecom ad · wwwincorporatecom​llc protect your personal assets gain tax advantages and more in minutes  step process start your business ready to incorporate llc vs corporation searches related toorbimed capital llc orbimed venture capital orbimed investments orbimed partners orbimed advisors orbimed new york orbimed asia orbimed israel orbimed mutual fund web results orbimed wwworbimedcom from biopharmaceuticals to medical devices digital health diagnostics and healthcare services orbimed is scouting the globe for innovations that will help ensure  portfolio contact us about us news orbimed capital llc  best investment advisors investmentadvisorscrediocomlorbimedcapitalllc find details on orbimed capital in new york new york view assets client details advisory activities registration status disclosures and more orbimed capital llc  financial services firm new york  httpswwwbrightscopecomfirmorbimedcapitalllc contact orbimed capital llc or view orbimed capital llcs ratings investment advice financial planning and insurance services and get detailed information on their  orbimed capital llc top holdings  whalewisdom httpswhalewisdomcomfilerorbimedcapitalllc detailed profile of orbimed capital llc portfolio of holdings sec filings include f quarterly reports dg events and more orbimed capital llc  new york  ny  company information httpswwwdandbcombusinessdirectoryorbimedcapitalllcnewyork find the orbimed capital llc business profile in new york  orbimed advisors llc private company information  wwwbloombergcomresearchstocksprivatesnapshotaspprivcapid orbimed advisors llc is a private equity and venture capital firm specializing in buyouts seed startups early stage middle market and growth capital  orbimed capital llc in new york ny   listingsfindthecompanycomlorbimedcapitalllcinnew orbimed capital llc is a security brokers and dealer located in new york new york view phone number website employees products revenue and more orbimed capital llc  bizapediacom httpswwwbizapediacomusorbimedcapitalllchtml there are  companies that go by the name of orbimed capital llc in albany ny and wilmington de orbimed capital llc part a of form adv brochure httpsadviserinfosecgoviapdcontentcommoncrdiapdbrochure orbimed capital llc part a of form adv brochure  lexington avenue th floor new york ny    wwworbimedcom updated march  get started on your llc today  simple  reliable process ad · wwwlegalzoomcom​llc start a limited liability company safeguard your personal assets how to start an llc llc pricing packages llc or corporation llc faqs set up an llc  get your business going today  incorporatecom ad · wwwincorporatecom​llc protect your personal assets gain tax advantages and more in minutes  step process start your business ready to incorporate llc vs corporation searches related toorbimed capital llc orbimed venture capital orbimed investments orbimed partners orbimed advisors orbimed new york orbimed asia orbimed israel orbimed mutual fund next answers covepoint capital advisors llc covepoint capital advisors llc is a privately held hedge fund which is based in new york city new york the fund started off as part of bear stearns more capital management group llc capital management group llc was an investment bank located in chicago illinois it was founded by shawn baldwin who was chairman and ceo of the more tricadia capital tricadia capital management llc tricadia capital is a new york based asset management company history tricadia capital is a multistrategy credit more search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network